First Graphene Limited (ASX:FGR) Responds to ASX Price Query
First Graphene Limited (ASX:FGR) addresses ASX concerns regarding price movements and highlights its ongoing commercial developments.
Category: Healthcare
Immuron Limited (ASX:IMC) Announces Travelan® Clinical Trial Update
Immuron Limited announces positive Phase 2 results for Travelan®, with FDA submission pending and strong immunology findings.
Matrix Composites & Engineering Ltd (ASX:MCE) Secures Major Contract
Matrix Composites secures a $7M contract from Stena Drilling for Deepwater Drilling Riser Buoyancy Systems, strengthening its market position.
Mesoblast Limited (ASX:MSB) Completes A$260 Million Capital Raise
Mesoblast Limited raises A$260M to fund the launch of Ryoncil and expand clinical development.
EQ Resources Ltd (ASX:EQR) Announces Leadership Transition
EQ Resources Ltd announces Kevin MacNeill’s transition to CTO as part of a growth strategy, focusing on operational improvements.
Tivan Limited (ASX: TVN) Reports Ultra High-Grade Fluorite Assays at Sandover
Tivan Limited (ASX: TVN) reveals ultra high-grade fluorite assays from the Sandover Project, indicating promising exploration and development potential.
Atomo Diagnostics Limited (ASX:AT1) Signs Long-Term Agreement for HIV Self-Testing
Atomo Diagnostics Limited (ASX:AT1) enters a five-year supply agreement with Newfoundland Diagnostics for its HIV self-testing products.
Bioxyne Limited (ASX:BXN) Announces Revenue Growth Plans
Bioxyne Limited (ASX:BXN) reports strong revenue growth projections and a manufacturing facility expansion in its latest investor update.
Magnetic Resources NL (ASX:MAU) Quarterly Report Highlights
Magnetic Resources NL reports significant drilling advancements at LJN4, with ongoing feasibility studies and encouraging gold recovery metrics.
Telix Pharmaceuticals Limited (ASX: TLX) Exceeds FY24 Revenue Guidance
Telix Pharmaceuticals reports a strong Q4 2024 performance, exceeding revenue guidance and advancing multiple therapeutic and imaging candidates.